Company intelligence / Profile preview
Vizuri Health Sciences Consumer Healthcare
- Ownership
- Private
- Development stage
- Phase 3
Overview
Vizuri Health Sciences Consumer Healthcare develops proprietary over-the-counter topical analgesic products using patented high-concentration capsaicin formulations aimed at safe and effective non-opioid management of arthritis and musculoskeletal pains. Its main commercial asset is PainBloc24®, widely distributed across U.S. retailers with supporting clinical evidence for osteoarthritis relief. In mid–2020 it spun off its prescription drug pipeline into Propella Therapeutics but continues to expand its consumer health portfolio under independent leadership.
- Therapeutic areas
- Rheumatology
- Modalities
- Topical small molecules (capsaicin-based formulations)
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Vizuri Health Sciences Consumer Healthcare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vizuri Health Sciences Consumer Healthcare.